<?xml version='1.0' encoding='utf-8'?>
<document id="27137712"><sentence text="Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol."><entity charOffset="68-79" id="DDI-PubMed.27137712.s1.e0" text="angiotensin" /><entity charOffset="115-134" id="DDI-PubMed.27137712.s1.e1" text="hydrochlorothiazide" /><entity charOffset="136-146" id="DDI-PubMed.27137712.s1.e2" text="amlodipine" /><entity charOffset="151-161" id="DDI-PubMed.27137712.s1.e3" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e0" e2="DDI-PubMed.27137712.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e0" e2="DDI-PubMed.27137712.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e0" e2="DDI-PubMed.27137712.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e0" e2="DDI-PubMed.27137712.s1.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e1" e2="DDI-PubMed.27137712.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e1" e2="DDI-PubMed.27137712.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e1" e2="DDI-PubMed.27137712.s1.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e2" e2="DDI-PubMed.27137712.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s1.e2" e2="DDI-PubMed.27137712.s1.e3" /></sentence><sentence text="LCZ696 is a first-in-class angiotensin receptor neprilysin inhibitor in development for treatments of hypertension and heart failure indications" /><sentence text=" In 3 separate studies, pharmacokinetic drug-drug interactions (DDIs) potential was assessed when LCZ696 was coadministered with hydrochlorothiazide (HCTZ), amlodipine, or carvedilol"><entity charOffset="129-148" id="DDI-PubMed.27137712.s3.e0" text="hydrochlorothiazide" /><entity charOffset="150-154" id="DDI-PubMed.27137712.s3.e1" text="HCTZ" /><entity charOffset="157-167" id="DDI-PubMed.27137712.s3.e2" text="amlodipine" /><entity charOffset="172-182" id="DDI-PubMed.27137712.s3.e3" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e0" e2="DDI-PubMed.27137712.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e0" e2="DDI-PubMed.27137712.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e0" e2="DDI-PubMed.27137712.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e0" e2="DDI-PubMed.27137712.s3.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e1" e2="DDI-PubMed.27137712.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e1" e2="DDI-PubMed.27137712.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e1" e2="DDI-PubMed.27137712.s3.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e2" e2="DDI-PubMed.27137712.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s3.e2" e2="DDI-PubMed.27137712.s3.e3" /></sentence><sentence text=" The studies used a open-label, single-sequence, 3-period, crossover design in healthy subjects" /><sentence text=" Blood samples were collected to determine the pharmacokinetic parameters of LCZ696 analytes (AHU377, LBQ657, and valsartan), HCTZ, amlodipine, or carvedilol (R[+]- and S[-]-carvedilol) for statistical analysis"><entity charOffset="114-123" id="DDI-PubMed.27137712.s5.e0" text="valsartan" /><entity charOffset="126-130" id="DDI-PubMed.27137712.s5.e1" text="HCTZ" /><entity charOffset="132-142" id="DDI-PubMed.27137712.s5.e2" text="amlodipine" /><entity charOffset="147-157" id="DDI-PubMed.27137712.s5.e3" text="carvedilol" /><entity charOffset="159-164" id="DDI-PubMed.27137712.s5.e4" text="R[+]-" /><entity charOffset="169-184" id="DDI-PubMed.27137712.s5.e5" text="S[-]-carvedilol" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e0" e2="DDI-PubMed.27137712.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e0" e2="DDI-PubMed.27137712.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e0" e2="DDI-PubMed.27137712.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e0" e2="DDI-PubMed.27137712.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e0" e2="DDI-PubMed.27137712.s5.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e0" e2="DDI-PubMed.27137712.s5.e5" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e1" e2="DDI-PubMed.27137712.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e1" e2="DDI-PubMed.27137712.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e1" e2="DDI-PubMed.27137712.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e1" e2="DDI-PubMed.27137712.s5.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e1" e2="DDI-PubMed.27137712.s5.e5" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e2" e2="DDI-PubMed.27137712.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e2" e2="DDI-PubMed.27137712.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e2" e2="DDI-PubMed.27137712.s5.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e2" e2="DDI-PubMed.27137712.s5.e5" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e3" e2="DDI-PubMed.27137712.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e3" e2="DDI-PubMed.27137712.s5.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e3" e2="DDI-PubMed.27137712.s5.e5" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e4" e2="DDI-PubMed.27137712.s5.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s5.e4" e2="DDI-PubMed.27137712.s5.e5" /></sentence><sentence text=" When coadministered LCZ696 with HCTZ, the 90% CIs of the geometric mean ratios of AUCtau,ss of HCTZ and that of LBQ657 were within a 0"><entity charOffset="33-47" id="DDI-PubMed.27137712.s6.e0" text="HCTZ" /><entity charOffset="96-110" id="DDI-PubMed.27137712.s6.e1" text="HCTZ" /><pair ddi="false" e1="DDI-PubMed.27137712.s6.e0" e2="DDI-PubMed.27137712.s6.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s6.e0" e2="DDI-PubMed.27137712.s6.e1" /></sentence><sentence text="80-1" /><sentence text="25 interval, whereas HCTZ Cmax,ss decreased by 26%, LBQ657 Cmax,ss increased by 19%, and the AUCtau,ss and Cmax,ss of valsartan increased by 14% and 16%, respectively"><entity charOffset="118-127" id="DDI-PubMed.27137712.s8.e0" text="valsartan" /><entity charOffset="21-29" id="DDI-PubMed.27137712.s8.e1" text="HCTZ" /><pair ddi="false" e1="DDI-PubMed.27137712.s8.e1" e2="DDI-PubMed.27137712.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s8.e1" e2="DDI-PubMed.27137712.s8.e0" /></sentence><sentence text=" Pharmacokinetics of amlodipine, R(+)- and S(-)-carvedilol, or LBQ657 were not altered after coadministration of LCZ696 with amlodipine or carvedilol"><entity charOffset="21-31" id="DDI-PubMed.27137712.s9.e0" text="amlodipine" /><entity charOffset="33-38" id="DDI-PubMed.27137712.s9.e1" text="R(+)-" /><entity charOffset="43-58" id="DDI-PubMed.27137712.s9.e2" text="S(-)-carvedilol" /><entity charOffset="125-135" id="DDI-PubMed.27137712.s9.e3" text="amlodipine" /><entity charOffset="139-149" id="DDI-PubMed.27137712.s9.e4" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e0" e2="DDI-PubMed.27137712.s9.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e0" e2="DDI-PubMed.27137712.s9.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e0" e2="DDI-PubMed.27137712.s9.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e0" e2="DDI-PubMed.27137712.s9.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e0" e2="DDI-PubMed.27137712.s9.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e1" e2="DDI-PubMed.27137712.s9.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e1" e2="DDI-PubMed.27137712.s9.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e1" e2="DDI-PubMed.27137712.s9.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e1" e2="DDI-PubMed.27137712.s9.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e2" e2="DDI-PubMed.27137712.s9.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e2" e2="DDI-PubMed.27137712.s9.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e2" e2="DDI-PubMed.27137712.s9.e4" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e3" e2="DDI-PubMed.27137712.s9.e3" /><pair ddi="false" e1="DDI-PubMed.27137712.s9.e3" e2="DDI-PubMed.27137712.s9.e4" /></sentence><sentence text=" Coadministration of LCZ696 400 mg once daily (qd) with HCTZ 25 mg qd, amlodipine 10 mg qd, or carvedilol 25 mg twice a day (bid) had no clinically relevant pharmacokinetic drug-drug interactions"><entity charOffset="71-81" id="DDI-PubMed.27137712.s10.e0" text="amlodipine" /><entity charOffset="95-105" id="DDI-PubMed.27137712.s10.e1" text="carvedilol" /><entity charOffset="56-65" id="DDI-PubMed.27137712.s10.e2" text="HCTZ" /><pair ddi="false" e1="DDI-PubMed.27137712.s10.e2" e2="DDI-PubMed.27137712.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s10.e2" e2="DDI-PubMed.27137712.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s10.e2" e2="DDI-PubMed.27137712.s10.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s10.e0" e2="DDI-PubMed.27137712.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s10.e0" e2="DDI-PubMed.27137712.s10.e1" /></sentence><sentence text=" LCZ696, HCTZ, amlodipine, and carvedilol were safe and well tolerated when given alone or concomitantly in the investigated studies"><entity charOffset="9-13" id="DDI-PubMed.27137712.s11.e0" text="HCTZ" /><entity charOffset="15-25" id="DDI-PubMed.27137712.s11.e1" text="amlodipine" /><entity charOffset="31-41" id="DDI-PubMed.27137712.s11.e2" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.27137712.s11.e0" e2="DDI-PubMed.27137712.s11.e0" /><pair ddi="false" e1="DDI-PubMed.27137712.s11.e0" e2="DDI-PubMed.27137712.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s11.e0" e2="DDI-PubMed.27137712.s11.e2" /><pair ddi="false" e1="DDI-PubMed.27137712.s11.e1" e2="DDI-PubMed.27137712.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27137712.s11.e1" e2="DDI-PubMed.27137712.s11.e2" /></sentence><sentence text="" /></document>